ISV-102

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameISV-102
Drug Alias Nametetracycline-based therapy (InSite Vision)ISV-102
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsEye Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInsite Vision Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsite Vision Incorporated
Active IndicationsN/A
Inactive IndicationsEye Infections

Other Information

ATC CodeN/A
Related LinksN/A